Invokana [package insert]
While it isnt typically life-threatening, it can cause serious complications: 160 people have been hospitalized in Michigan since the outbreak began
The most recent update serves as a thorough guide to navigating the shortage, offering solutions to a range of dilemmas that could arise when treating a person who may benefit from a GLP-1 RA
In a large cardiovascular outcomes trial [see Clinical Studies (14.5)], BYDUREON was studied in 2,959 patients (40%) who were at least 65 years old and of those, 605 patients (8%) were at least 75 years old
Another study also found that acylcarnitine C3:0 was decreased in the end-stage renal disease (ESRD) with depression than those without depression and C3:0 had a good ability to diagnose depression in the ESRD (AUC = 0.934) (42)
Typically, you cant just start compounding a patented drug without permission